A dilemma for mucosal vaccination: efficacy versus toxicity using enterotoxin-based adjuvants

By Fujihashi K.   Koga T.   van Ginkel F.W.   Hagiwara Y.   McGhee J.R.  

Vaccine, Vol. 20, Iss. 19, 2002-06 ,pp. : 2431-2438

Elsevier

Access to resources Recommend Favorite

Antibody responses and protection against influenza virus infection in different congenic strains of mice immunized intranasally with adjuvant-combined A/Beijing/262/95 (H1N1) virus hemagglutinin or neuraminidase

By Yoshikawa T.   Suzuki Y.   Nomoto A.   Sata T.   Kurata T.   Tamura S.-i.  

Vaccine, Vol. 21, Iss. 1, 2002-11 ,pp. : 60-66

Elsevier

Access to resources Recommend Favorite

Comparison of 24 different adjuvants for inactivated HIV-2 split whole virus as antigen in mice. Induction of titres of binding antibodies and toxicity of the formulations

By Stieneker F.   Kersten G.   van Bloois L.   Crommelin D.J.A.   Hem S.L.   Lower J.   Kreuter J.  

Vaccine, Vol. 13, Iss. 1, 1995-01 ,pp. : 45-53

Elsevier

Access to resources Recommend Favorite

Therapeutic efficacy of hepatitis B surface antigen-antibodies-recombinant DNA composite in HBsAg transgenic mice

By Zheng B.-J.   Ng M.-H.   He L.-F.   Yao X.   Chan K.-W.   Yuen K.-Y.   Wen Y.-M.  

Vaccine, Vol. 19, Iss. 30, 2001-07 ,pp. : 4219-4225

Elsevier

Access to resources Recommend Favorite

Vaccination of mice with live recombinant Salmonella typhimurium aroA against H. pylori: parameters associated with prophylactic and therapeutic vaccine efficacy

By Koesling J.   Lucas B.   Develioglou L.   Aebischer T.   Meyer T.F.  

Vaccine, Vol. 20, Iss. 3, 2001-11 ,pp. : 413-420

Elsevier

Access to resources Recommend Favorite